LATEST UPDATES
Card-image-cap

Market | Public & Private Offers

Neimeth International Pharmaceuticals Plc Obtains SEC Approval to Extend Its Rights Issue by Fifteen (15) Working Days

Aug 28, 2022   •   by   •   Source: NGX   •   eye-icon 322 views

We refer to our market bulletin of 3 August 2022 with reference number: NGXREG/LRD/MB48/22/08/03 whereby the market was notified that trading in Neimeth International Pharmaceuticals Plc’s Rights Issue of 2,373,947,500 ordinary shares of 50 Kobo each at N1.55 per share on the basis of five (5) new ordinary shares for every four (4) ordinary shares held as at the close of business on Friday, 22 April 2022 (Neimeth’s Rights) opened on Wednesday, 3 August 2022 and will continue until Thursday 25 August 2022. 

 

Neimeth International Pharmaceuticals Plc has obtained the approval of the Securities and Exchange Commission’s (SEC) to extend Neimeth’s Rights by fifteen (15) working days.

 

Consequently, trading in Neimeth’s Rights will now close on Thursday, 15 September 2022. 

 

Below are details of the Rights:

Related items.

Get the App

apple-store  play-store

Connect with us


Proshare is a professional practice focused on delivering research and information services to bridge the gap between investors and markets; by delivery on credible, reliable, and timely engagements through the following areas — Impact Research, Market Intelligence, Strategic Advisory, Stakeholder Relations & Digital Media.